Effect of cabergoline on thyroid function in hyperprolactinaemia.
Keogh
M A
MA
Wittert
G A
GA
D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D010911:Pituitary Neoplasms / Q000097:blood / Q000188:drug therapy*; D015175:Prolactinoma / Q000097:blood / Q000188:drug therapy*; D012189:Retrospective Studies; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood
D018491:Dopamine Agonists; D004873:Ergolines; D013972:Thyrotropin; D000077465:Cabergoline; D013974:Thyroxine